Document 0163 DOCN M94A0163 TI Impaired parathyroid hormone release in human immunodeficiency virus infection. DT 9412 AU Hellman P; Albert J; Gidlund M; Klareskog L; Rastad J; Akerstrom G; Juhlin C; Department of Surgery, University Hospital, Uppsala, Sweden. SO AIDS Res Hum Retroviruses. 1994 Apr;10(4):391-4. Unique Identifier : AIDSLINE MED/94347463 AB Patients with human immunodeficiency virus type 1 (HIV-1) seropositivity exhibited significantly lower intact serum parathyroid hormone (PTH) values (mean, 13.6 ng/liter; n = 44) than healthy controls (mean, 38.1 ng/liter; p < 0.001; n = 50). The reduction was greater among patients with no or mild immunodeficiency (> 400 x 10(6) CD4+ lymphocytes/ml blood; n = 22) than in those with severe immunodeficiency (< 200 x 10(6) CD4+ lymphocytes/ml blood; n 22; p = 0.03), although total serum calcium was normal in all groups. Patients with severe immunodeficiency demonstrated an inverse correlation between total serum calcium and serum PTH (r2 = 0.367; p < 0.01), which was also present in healthy controls (r2 = 0.482; p < 0.001), but not among the seropositive patients with no or mild immunodeficiency (r2 = 0.017; p = 0.58). Parathyroid cells express a protein recognized by antibodies directed against CD4, the HIV-1 receptor. This implies that these cells may be directly infected with HIV-1 and also interact with circulating autoantibodies against CD4, thus resulting in impaired PTH release. DE Antigens, CD4/IMMUNOLOGY Autoantibodies/BLOOD Calcium/BLOOD Female Human HIV Infections/*BLOOD/IMMUNOLOGY *HIV-1 Leukocyte Count Male Parathyroid Glands/IMMUNOLOGY Parathyroid Hormones/BLOOD/*DEFICIENCY/SECRETION Support, Non-U.S. Gov't T4 Lymphocytes JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).